Titlebook: Difficult Decisions in Thoracic Surgery; An Evidence-Based Ap Mark K. Ferguson Book 20112nd edition Springer-Verlag London Limited 2011 Gen

monogamy

Decision Making: The Patient’s Perspective counseling, patients score ‘D’ on knowledge tests and ‘F’ on their understanding of the probabilities of benefits and harms. Moreover, there is a mismatch between the benefits and harms that patients value most and the option that is chosen. Patients participate in decision making less than they pr

逃避現(xiàn)實(shí)

PET for Mediastinal Restaging of Patients with Non Small Cell Lung Cancer after Induction Therapyancer (NSCLC) continues to be a challenge. Identifying pathological N2 disease is of importance because it significantly affects outcomes and potential treatment strategies. More widespread utilization of endobronchial ultrasound techniques and refinements in fluorodeoxyglucose positron emission tom

多產(chǎn)魚(yú)

Optimal Initial Pathologic Mediastinal Staging of Lung Cancer: EUS, EBUS, Mediastinoscopy, mediastinal lymph node staging is an important branch point in deciding therapy. The initial clinical evaluation of patients with suspected lung cancer includes a contrast CT scan of the chest and upper abdomen that provides staging information about the T descriptor and usually leads to a presump

Between

VATS vs. Open Lobectomy for Early Stage Non-Small Cell Lung Cancer(American Joint Committee on Cancer [AJCC] stage I and II) non-small cell lung cancer (NSCLC).. Patients with untreated stage I NSCLC, albeit an early stage neoplasm, have a 5-year survival rate of less than 5%.. – . Radiation and chemotherapy (alone or in combination) offer little survival benefit.

老巫婆

疾馳

placebo-effect

Lobectomy After Induction Therapy for Stage IIIA NSCLC in the Presence of Persistent N2 Diseaseiverse clinical scenarios (Table 11.1).. For many of these N2 subsets the therapeutic options are well known and are accepted in the clinical practice.. Patients with potentially resectable N2 disease detected preoperatively usually undergo induction treatment (chemotherapy and/or chemoradiotherapy)

減震

教育學(xué)

不能仁慈

Optimal Therapy for Patients with Marginal Lung Function and Peripheral Stage I Lung Cancer lower the FEV1%, the higher the risk of developing NSCLC.. Due to the association between both diseases, COPD patients are frequently referred for lung resection for NSCLC. In this chapter we review recently published evidence regarding the best therapeutic option for stage I NSCLC patients with ma